Schedule 13G ownership disclosure

ANI Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 00182C103

Event date: 2025-05-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 1,108,127.00 · Class: 5.1%

  • Millennium Management LLC

    Shares: 1,116,660.00 · Class: 5.2%

  • Millennium Group Management LLC

    Shares: 1,116,660.00 · Class: 5.2%

  • Israel A. Englander

    Shares: 1,116,660.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-056380
Form type
SCHEDULE 13G
Filer
ANI PHARMACEUTICALS INC
CIK
CIK 1023024
Filed
Jun 04, 2025
Reporting period
May 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub